Funder
Takeda Pharmaceutical Company
Sanofi Genzyme
Subject
Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)
Reference51 articles.
1. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy;Desnick;Ann Intern Med,2003
2. Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions;Kok;Biomolecules,2021
3. Anderson-Fabry disease: a multiorgan disease;Tuttolomondo;Curr Pharm Des,2013
4. Lyso-Gb3 activates Notch1 in human podocytes;Sanchez-Niño;Hum Mol Genet,2015
5. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy;Schiffmann;Nephrol Dial Transplant,2009
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献